Misbah S - Search Results

1

Subcutaneous immunoglobulin: opportunities and outlook.

Misbah S, Sturzenegger MH, Borte M, Shapiro RS, Wasserman RL, Berger M, Ochs HD. Misbah S, et al. Clin Exp Immunol. 2009 Dec;158 Suppl 1(Suppl 1):51-9. doi: 10.1111/j.1365-2249.2009.04027.x. Clin Exp Immunol. 2009. PMID: 19883424 Free PMC article. Review.

2

Antipolysaccharide antibodies in 450 children with otitis media.

Misbah SA, Griffiths H, Mitchell T, Freeland A, Haeney MR, Chapel HM. Misbah SA, et al. Clin Exp Immunol. 1997 Jul;109(1):67-72. doi: 10.1046/j.1365-2249.1997.4291322.x. Clin Exp Immunol. 1997. PMID: 9218826 Free PMC article. Clinical Trial.

3

Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.

Ferry BL, Misbah SA, Stephens P, Sherrell Z, Lythgoe H, Bateman E, Banner C, Jones J, Groome N, Chapel HM. Ferry BL, et al. Among authors: misbah sa. Clin Exp Immunol. 2004 May;136(2):297-303. doi: 10.1111/j.1365-2249.2004.02439.x. Clin Exp Immunol. 2004. PMID: 15086394 Free PMC article.

4

Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.

Ferry BL, Jones J, Bateman EA, Woodham N, Warnatz K, Schlesier M, Misbah SA, Peter HH, Chapel HM. Ferry BL, et al. Among authors: misbah sa. Clin Exp Immunol. 2005 Jun;140(3):532-9. doi: 10.1111/j.1365-2249.2005.02793.x. Clin Exp Immunol. 2005. PMID: 15932516 Free PMC article.

5

An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.

Arnold DF, Burton J, Shine B, Wojnarowska F, Misbah SA. Arnold DF, et al. Among authors: misbah sa. Br J Dermatol. 2009 May;160(5):1098-102. doi: 10.1111/j.1365-2133.2009.09034.x. Epub 2009 Feb 16. Br J Dermatol. 2009. PMID: 19222460 Clinical Trial.

6

An approach to the diagnosis and management of systemic vasculitis.

Miller A, Chan M, Wiik A, Misbah SA, Luqmani RA. Miller A, et al. Among authors: misbah sa. Clin Exp Immunol. 2010 May;160(2):143-60. doi: 10.1111/j.1365-2249.2009.04078.x. Epub 2010 Jan 12. Clin Exp Immunol. 2010. PMID: 20070316 Free PMC article. Review.

7

Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.

Lucas M, Hugh-Jones K, Welby A, Misbah S, Spaeth P, Chapel H. Lucas M, et al. Among authors: misbah s. J Clin Immunol. 2010 May;30 Suppl 1:S84-9. doi: 10.1007/s10875-010-9400-y. J Clin Immunol. 2010. PMID: 20387103 Free article. Review.

8

A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.

Misbah SA, Baumann A, Fazio R, Dacci P, Schmidt DS, Burton J, Sturzenegger M. Misbah SA, et al. J Peripher Nerv Syst. 2011 Jun;16(2):92-7. doi: 10.1111/j.1529-8027.2011.00330.x. J Peripher Nerv Syst. 2011. PMID: 21692906 Clinical Trial.

9

Bringing immunoglobulin knowledge up to date: how should we treat today?

Misbah S, Kuijpers T, van der Heijden J, Grimbacher B, Guzman D, Orange J. Misbah S, et al. Clin Exp Immunol. 2011 Oct;166(1):16-25. doi: 10.1111/j.1365-2249.2011.04443.x. Epub 2011 Jul 15. Clin Exp Immunol. 2011. PMID: 21762127 Free PMC article. Review.

10

Should therapeutic immunoglobulin be considered a generic product? An evidence-based approach.

Misbah SA. Misbah SA. J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):567-72. doi: 10.1016/j.jaip.2013.09.009. Epub 2013 Oct 31. J Allergy Clin Immunol Pract. 2013. PMID: 24565702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters